Physician profile
Timothy Geering
NPI 1265495048
$3,306.63
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,761 · 2020: $729 · 2021: $801 · 2022: $15.97.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $390.77 | 2019-2021 | |
| Lilly USA, LLC | $322.90 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $318.13 | 2019-2021 | |
| Pfizer INC. | $311.68 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $257.30 | 2019-2021 | |
| Amgen INC. | $249.99 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $213.46 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $158.22 | 2019 | |
| Sanofi-Aventis U.S. LLC | $118.48 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $111.70 | 2020-2021 | |
| Abbvie INC. | $108.20 | 2019-2022 | |
| Radius Health, INC. | $99.75 | 2019-2021 | |
| Glaxosmithkline, LLC. | $99.32 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.22 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $68.76 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $60.86 | 2019 | |
| Astellas Pharma US INC | $41.15 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.76 | 2019 | |
| Allergan, INC. | $36.31 | 2019-2020 | |
| Genentech USA, INC. | $31.57 | 2020-2021 | |
| Amarin Pharma, INC. | $31.52 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $26.69 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $24.14 | 2019-2020 | |
| Cranial Technologies, INC | $22.07 | 2019 | |
| Grifols USA, LLC | $19.86 | 2020 | |
| Esperion Therapeutics, INC. | $15.65 | 2020 | |
| Antares Pharma, INC. | $15.53 | 2019 | |
| Vivus LLC | $15.29 | 2020 | |
| Dexcom, INC. | $12.27 | 2021 | |
| Novartis Pharmaceuticals Corporation | $11.08 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Geering listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.